Immunology

Macular degeneration linked to aging immune cells

As people age, their immune systems age, too. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause ...

Medical research

Eye's recycling process key to seeing color, bright light

As many of us learned in high school science class, the retina's rods and cones allow us to see. Rods are for night vision, and cones operate in bright light and allow us to distinguish colors. But although scientists have ...

Medications

FDA approves Regeneron's eye injection Eylea

(AP) -- Regulators on Friday approved Regeneron Pharmaceuticals Inc.'s drug Eylea, an injection designed to treat a common cause of blindness in older people.

Ophthalmology

New gene therapy for vision loss proven safe in humans

In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...

Ophthalmology

Plastic membrane to treat age-related macular degeneration

A porous polymeric scaffold might be the answer to a sight problem that afflicts millions of older people every year, age-related macular degeneration. Researchers writing in the International Journal of Biomedical Engineering ...

page 6 from 39